Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

51,315 studies for “California”

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerRecruiting
NCT07195734Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Locally Recurrent Head and Neck Squamous Cell Carcinoma · Locally Recurrent Hypopharyngeal Squamous Cell Carcinoma
United States
QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic MelanomaTerminated
NCT01029873Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Altor BioScience
Metastatic Melanoma
United States
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)Recruiting
NCT05564390Phase 2Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy · Acute Myeloid Leukemia, Myelodysplasia-Related
United States, Canada, Puerto Rico
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low TrialRecruiting
NCT07391774Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8 · Anatomic Stage IIIC Breast Cancer AJCC v8 · Estrogen Receptor-Positive Breast Carcinoma
United States, Puerto Rico
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung CarcinomaSuspended
NCT06014827Phase 2Updated Sep 10, 2026
Sponsor: City of Hope Medical Center
Lung Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)Active Not Recruiting
NCT05925803Phase 3Updated Sep 10, 2026
Sponsor: AstraZeneca
Systemic Sclerosis · Scleroderma
United States, Austria, Belgium, Canada, China +18 more
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerRecruiting
NCT03424005Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Australia, France, Germany, Israel +4 more
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian TumorsRecruiting
NCT06646627Phase 1Updated Sep 10, 2026
Sponsor: Stanford University
Ovarian Cancer
United States
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)Recruiting
NCT06024746Phase 3Updated Sep 10, 2026
Sponsor: Colorado Prevention Center
Heart Failure
United States, Brazil, Canada, China, India +3 more
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCCRecruiting
NCT07462377Phase 1Updated Sep 10, 2026
Sponsor: EpiBiologics
Epidermal Growth Factor · Epidermal Growth Factor Receptor · Epidermal Growth Factor Receptor Gene Mutation · Non Small Cell
United States
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or CarcinosarcomaRecruiting
NCT05256225Phase 3Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Endometrial Carcinoma · Endometrial Clear Cell Adenocarcinoma · Endometrial Dedifferentiated Carcinoma · Endometrial Endometrioid Adenocarcinoma
United States, Puerto Rico, South Korea
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLPEnrolling By Invitation
NCT05883748Phase 2, Phase 3Updated Sep 10, 2026
Sponsor: Disc Medicine, Inc
Erythropoietic Protoporphyria
United States, Australia, Belgium, France, Germany +6 more
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCCRecruiting
NCT04864054Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Eureka Therapeutics Inc.
Hepatocellular Carcinoma · Liver Cancer, Adult · Liver Neoplasm · Metastatic Liver Cancer
United States, Taiwan
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)Active Not Recruiting
NCT05051033NAUpdated Sep 10, 2026
Sponsor: Annetine Gelijns
Mitral Valve Regurgitation
United States, Canada, Germany, Spain, United Kingdom
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)Recruiting
NCT06708299Phase 3Updated Sep 10, 2026
Sponsor: Cardiol Therapeutics Inc.
Recurrent Pericarditis
United States, Canada, Greece, Italy
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerActive Not Recruiting
NCT04514497Phase 1Updated Sep 10, 2026
Sponsor: National Cancer Institute (NCI)
Metastatic Lung Small Cell Carcinoma · Metastatic Malignant Solid Neoplasm · Metastatic Neuroendocrine Carcinoma · Metastatic Pancreatic Adenocarcinoma
United States
Stereotactic Adaptive Radiation Therapy of Borderline Resectable Pancreatic Cancer an Individualized ApproachRecruiting
NCT05764720NAUpdated Sep 10, 2026
Sponsor: Varian, a Siemens Healthineers Company
Pancreatic Cancer
United States
BPL-003 Efficacy and Safety in Treatment Resistant DepressionCompleted
NCT05870540Phase 2Updated Sep 10, 2026
Sponsor: Beckley Psytech Limited
Treatment Resistant Depression
United States, Australia, Germany, Poland, Spain +1 more
Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).Recruiting
NCT06623409Phase 1Updated Sep 10, 2026
Sponsor: Merck Sharp & Dohme LLC
Healthy
United States
Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain MetastasesActive Not Recruiting
NCT05438212Phase 3Updated Sep 10, 2026
Sponsor: NRG Oncology
Metastatic Malignant Neoplasm in the Brain
United States, Canada, Japan
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesActive Not Recruiting
NCT05589896Phase 1, Phase 2Updated Sep 10, 2026
Sponsor: Ossium Health, Inc.
Acute Leukemia · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Acute Biphenotypic Leukemia
United States
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Recruiting
NCT07032662Phase 2Updated Sep 10, 2026
Sponsor: Immunovant Sciences GmbH
Chronic Inflammatory Demyelinating Polyneuropathy
United States, Argentina, Australia, Austria, Belgium +25 more
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's DiseaseRecruiting
NCT07717411Phase 3Updated Sep 10, 2026
Sponsor: Hoffmann-La Roche
Alzheimer's Disease
United States, Canada, China, United Kingdom
Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate CancerRecruiting
NCT05766371Phase 2Updated Sep 10, 2026
Sponsor: University of California, San Francisco
Castrate Resistant Prostate Cancer · Metastatic Castration-resistant Prostate Cancer · Prostate Cancer · Prostate Carcinoma
United States
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)Recruiting
NCT07218354Phase 3Updated Sep 10, 2026
Sponsor: VA Office of Research and Development
Alcohol Use Disorder
United States

51,315 studies found